Table 2. Morphological and positive pixel analysis, using three methods of analysis.
| Variables | Group | Average | St Dev | Median | Est diff | Confid Int (95%) | P* | |
|---|---|---|---|---|---|---|---|---|
| Vessel number (HotSpot) | Thrombus | 74.3 | 47.38 | 52.5 | −45.9 | −102.9 | 11.114 | 0.1019 |
| Tumour | 120.2 | 46.36 | 117.5 | |||||
| Vascular area (HotSpot) | Thrombus | 52,086.62 | 32,302 | 49,759.15 | 3,308.4 | −19,564 | 26,181 | 0.751 |
| Tumour | 48,778.21 | 20,511 | 46,933.07 | |||||
| PSMA (HotSpot) | Thrombus | 0.47 | 0.15 | 0.5 | −0.025 | −0.161 | 0.1113 | 0.6888 |
| Tumour | 0.49 | 0.07 | 0.5 | |||||
| CD34 (HotSpot) | Thrombus | 0.29 | 0.11 | 0.28 | 0.0395 | −0.057 | 0.136 | 0.3784 |
| Tumour | 0.25 | 0.07 | 0.25 | |||||
| PSMA/CD34 (HotSpot) | Thrombus | 1.66 | 1.29 | 1.22 | 0.9469 | 0.1295 | 1.7644 | 0.0278* |
| Tumour | 0.71 | 0.25 | 0.69 | |||||
| PSMA (10 HPF Avg) | Thrombus | 0.32 | 0.16 | 0.33 | −0.049 | −0.185 | 0.086 | 0.4309 |
| Tumour | 0.37 | 0.08 | 0.39 | |||||
| CD34 (10 HPF Avg) | Thrombus | 0.19 | 0.11 | 0.16 | 0.0236 | −0.064 | 0.111 | 0.556 |
| Tumour | 0.16 | 0.06 | 0.18 | |||||
| PSMA/CD34 (10 HPF Avg) | Thrombus | 0.74 | 0.26 | 0.71 | 0.2704 | 0.0884 | 0.4523 | <0.01* |
| Tumour | 0.47 | 0.16 | 0.46 | |||||
| CD34 (total) | Thrombus | 0.3 | 0.17 | 0.28 | −0.067 | −0.202 | 0.0687 | 0.2937 |
| Tumour | 0.37 | 0.07 | 0.37 | |||||
| PSMA (total) | Thrombus | 0.18 | 0.11 | 0.18 | 0.0325 | −0.063 | 0.1276 | 0.4593 |
| Tumour | 0.15 | 0.06 | 0.14 | |||||
| PSMA/CD34 (total) | Thrombus | 0.64 | 0.2 | 0.64 | 0.2323 | 0.0718 | 0.3927 | <0.01* |
| Tumour | 0.4 | 0.15 | 0.39 | |||||
(I) HotSpot, the most vascular field analyzed; (II) average values obtained from 10 high powered fields (10 HPF Avg); (III) total slide section positive pixel analysis. St Dev, standard deviation; Est Diff, estimated difference; Confid Int, confidence interval. *, P value with <0.05 significance.